A new paradigm of the pathogenesis of primary sclerosing cholangitis associated with ulcerative colitis: microbiota and system intestine-liver. A review
Open Access
- 7 March 2026
- journal article
- review article
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (2) , 119-124
Abstract
The close relationship between primary sclerosing cholangitis and ulcerative colitis has given rise to a number of hypotheses aimed at deciphering their pathogenesis from the standpoint of bidirectional connections involving immune, endocrine and inflammatory mechanisms. The review examines the main directions of the concept of the "gut-liver axis" from the point of view of the pathogenetic relationships of primary sclerosing cholangitis associated with ulcerative colitis and intestinal microbiota.Keywords
This publication has 52 references indexed in Scilit:
- Primary sclerosing cholangitis—A long night's journey into dayClinical Liver Disease, 2022
- Increased risk of cancer in patients with primary sclerosing cholangitisHepatology International, 2021
- The Use of Rifaximin in Patients With CirrhosisHepatology, 2021
- Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitisHepatology, 2015
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitisHepatology, 2013
- Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing CholangitisJournal of Clinical Immunology, 2012
- Gut Immune Maturation Depends on Colonization with a Host-Specific MicrobiotaCell, 2012
- Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic reviewJournal of Hepatology, 2012
- Increased Risk of Primary Sclerosing Cholangitis and Ulcerative Colitis in First-Degree Relatives of Patients With Primary Sclerosing CholangitisClinical Gastroenterology and Hepatology, 2008
- Metronidazole and Ursodeoxycholic Acid for Primary Sclerosing Cholangitis: A Randomized Placebo–Controlled TrialHepatology, 2004